Concepedia

Danielle Murray

DM

Statistics

Publications

14

Citations

1.3K

H-Index

13

Active since

2010

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

University of Toronto

Peter MacCallum Cancer Centre

Stanford University

Danielle Murray is an author at National Institutes of Health specializing in antiretroviral therapy, life sciences, and immunology.

ORCID

Publications per year

2010–2020

14

Publications

14

Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

Steven A. Yukl, Eli Boritz, Michael P. Busch et al. · PLoS Pathogens · 2013 · 290 citations · Full text

, , +15

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

Tae Wook Chun, J. Shawn Justement, Danielle Murray et al. · AIDS · 2010 · 288 citations · Full text

, , +14

Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo

Elizabeth J. Beans, Dennis N. Fournogerakis, Carolyn Gauntlett et al. · Proceedings of the National Academy of Sciences · 2013 · 148 citations · Full text

, , +17

Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy

Tae‐Wook Chun, B. W. Belay, Danielle Murray et al. · The Journal of Infectious Diseases · 2012 · 96 citations · Full text

, , +17

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

Matthew D. Marsden, Brian A. Loy, Xiaomeng Wu et al. · PLoS Pathogens · 2017 · 94 citations · Full text

, , +17

1–5 of 14